PRODUCT
Summary
TCIRG1 peptide is used for blocking the activity of TCIRG1 antibody (catalog number GTX32087).
APPLICATION
Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
Assay dependent |
Not tested in other applications.
PROPERTIES
Form
Liquid
Buffer
PBS, 0.1% BSA
Preservative
0.02% Sodium azide
Storage
Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.
Concentration
200 μg/ml (Please refer to the vial label for the specific concentration.)
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
TARGET
Synonyms
T Cell Immune Regulator 1, Atpase H+ Transporting V0 Subunit A3 , Atp6N1C , Atp6V0A3 , Atp6I , Oc-116Kda , Oc116 , Optb1 , Stv1 , Tirc7 , Vph1 , A3 , Tcirg1
Background
Through alternate splicing, this gene encodes two proteins with similarity to subunits of the vacuolar ATPase (V-ATPase) but the encoded proteins seem to have different functions. V-ATPase is a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, and receptor-mediated endocytosis. V-ATPase is comprised of a cytosolic V1 domain and a transmembrane V0 domain. Mutations in this gene are associated with infantile malignant osteopetrosis. [provided by RefSeq, Jul 2008]
Research Area
REFERENCE
There are currently no references for TCIRG1 blocking peptide (GTX32087-PEP). Be the first to share your publications with this product.
REVIEW
There are currently no reviews for TCIRG1 blocking peptide (GTX32087-PEP). Be the first to share your experience with this product.